Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 2626.17 | 1808 / 1809 | 100% | 28.81 | 470 / 472 |
esophagus | 99% | 1827.94 | 1433 / 1445 | 100% | 26.15 | 183 / 183 |
lung | 100% | 3157.14 | 578 / 578 | 99% | 19.18 | 1145 / 1155 |
thymus | 100% | 1754.59 | 651 / 653 | 99% | 31.57 | 599 / 605 |
uterus | 100% | 1683.39 | 170 / 170 | 98% | 23.98 | 452 / 459 |
breast | 100% | 1969.87 | 459 / 459 | 98% | 17.50 | 1098 / 1118 |
intestine | 97% | 1112.24 | 939 / 966 | 100% | 19.00 | 526 / 527 |
ovary | 98% | 1460.36 | 177 / 180 | 99% | 20.77 | 424 / 430 |
bladder | 95% | 1149.14 | 20 / 21 | 98% | 21.24 | 496 / 504 |
adrenal gland | 100% | 1349.28 | 257 / 258 | 90% | 11.16 | 207 / 230 |
kidney | 98% | 1193.04 | 87 / 89 | 90% | 15.12 | 810 / 901 |
stomach | 86% | 977.67 | 307 / 359 | 100% | 18.77 | 285 / 286 |
pancreas | 86% | 708.41 | 283 / 328 | 99% | 35.87 | 176 / 178 |
brain | 69% | 497.15 | 1826 / 2642 | 97% | 15.02 | 682 / 705 |
prostate | 96% | 1146.72 | 236 / 245 | 68% | 6.07 | 342 / 502 |
liver | 50% | 392.83 | 114 / 226 | 55% | 6.11 | 224 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.69 | 29 / 29 |
spleen | 100% | 1737.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.33 | 1 / 1 |
adipose | 100% | 2478.15 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2329.77 | 1328 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3402.48 | 923 / 929 | 0% | 0 | 0 / 0 |
heart | 87% | 934.00 | 751 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 9.61 | 68 / 80 |
muscle | 33% | 182.65 | 266 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090166 | Biological process | Golgi disassembly |
GO_0031122 | Biological process | cytoplasmic microtubule organization |
GO_0007113 | Biological process | endomitotic cell cycle |
GO_2000777 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia |
GO_0007052 | Biological process | mitotic spindle organization |
GO_0009314 | Biological process | response to radiation |
GO_0044819 | Biological process | mitotic G1/S transition checkpoint signaling |
GO_0006974 | Biological process | DNA damage response |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006970 | Biological process | response to osmotic stress |
GO_0051302 | Biological process | regulation of cell division |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1904716 | Biological process | positive regulation of chaperone-mediated autophagy |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0000302 | Biological process | response to reactive oxygen species |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_0006915 | Biological process | apoptotic process |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0006468 | Biological process | protein phosphorylation |
GO_0090316 | Biological process | positive regulation of intracellular protein transport |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0032465 | Biological process | regulation of cytokinesis |
GO_0005795 | Cellular component | Golgi stack |
GO_0005730 | Cellular component | nucleolus |
GO_0000922 | Cellular component | spindle pole |
GO_0005813 | Cellular component | centrosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0002039 | Molecular function | p53 binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PLK3 |
Protein name | Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) |
Synonyms | CNK FNK PRK |
Description | FUNCTION: Serine/threonine-protein kinase involved in cell cycle regulation, response to stress and Golgi disassembly. Polo-like kinases act by binding and phosphorylating proteins that are already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates ATF2, BCL2L1, CDC25A, CDC25C, CHEK2, HIF1A, JUN, p53/TP53, p73/TP73, PTEN, TOP2A and VRK1. Involved in cell cycle regulation: required for entry into S phase and cytokinesis. Phosphorylates BCL2L1, leading to regulate the G2 checkpoint and progression to cytokinesis during mitosis. Plays a key role in response to stress: rapidly activated upon stress stimulation, such as ionizing radiation, reactive oxygen species (ROS), hyperosmotic stress, UV irradiation and hypoxia. Involved in DNA damage response and G1/S transition checkpoint by phosphorylating CDC25A, p53/TP53 and p73/TP73. Phosphorylates p53/TP53 in response to reactive oxygen species (ROS), thereby promoting p53/TP53-mediated apoptosis. Phosphorylates CHEK2 in response to DNA damage, promoting the G2/M transition checkpoint. Phosphorylates the transcription factor p73/TP73 in response to DNA damage, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates HIF1A and JUN is response to hypoxia. Phosphorylates ATF2 following hyperosmotic stress in corneal epithelium. Also involved in Golgi disassembly during the cell cycle: part of a MEK1/MAP2K1-dependent pathway that induces Golgi fragmentation during mitosis by mediating phosphorylation of VRK1. May participate in endomitotic cell cycle, a form of mitosis in which both karyokinesis and cytokinesis are interrupted and is a hallmark of megakaryocyte differentiation, via its interaction with CIB1. . |
Accessions | ENST00000372201.5 Q9H4B4 |